Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-26-326783
Filing Date
2026-07-31
Accepted
2026-07-31 07:22:50
Documents
1
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 7481
  Complete submission text file 0001193125-26-326783.txt   9358
Mailing Address JOHANNES VERMEERPLEIN 9 AMSTERDAM Netherlands
Business Address JOHANNES VERMEERPLEIN 9 AMSTERDAM Netherlands 31-20-664-5500
LSP V Cooperatieve U.A. (Filed by) CIK: 0001726006 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7
Type: SCHEDULE 13G/A

Mailing Address J.H. OORTWEG 21 2333 CH LEIDEN LEIDEN Netherlands
Business Address J.H. OORTWEG 21 2333 CH LEIDEN LEIDEN Netherlands 31 (0)71 203 6410
Pharvaris N.V. (Subject) CIK: 0001830487 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-92181 | Film No.: 261225417
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)